ECHELON BIOSCIENCES, INC. — Department of Health and Human Services SBIR Phase II: This contract addresses the need for reliable and accurate biomarkers of alcohol consumpti
ECHELON BIOSCIENCES, INC. — SBIR Phase II award from Department of Health and Human Services.
- Amount
- $625,360
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase II
- NAICS
- —
- Place of performance
- UT
- Period
- —
Description
This contract addresses the need for reliable and accurate biomarkers of alcohol consumption, initially in response to a National Institute on Alcohol Abuse and Alcoholism (NIAAA)-initiated Small Business Innovation Research (SBIR) contract topic on Biomarkers for Alcohol-induced Disorders. The goals of this contract are to advance the usefulness of phosphatidylethanol (PEth), an alcohol metabolite, as a clinical biomarker of alcohol consumption, by designing an antibody-based method of quantitation that ischeaper and more accessible to small hospitals and clinics than currently used chromatographic/ spectrophotometric methods. This contract is a continuation of a Phase II SBIR contract with Echelon Biosciences, Inc. It was awarded under SBIR solicitation PHS-2008-1, Topic 031. This effort is deemed to be non-severable. PUBLIC HEALTH RELEVANCE